Clinical Trials Insight: 700042652

Trial Profile

Clinical Trials Insight: 700042652

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Oct 2009

At a glance

  • Drugs Granisetron (Primary)
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Adverse reactions
  • Sponsors Solasia Pharma
  • Most Recent Events

    • 31 Oct 2009 Status changed from recruiting to completed, according to a Solasia Pharma media release.
    • 19 Mar 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top